2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- PMID: 36017548
- DOI: 10.1093/eurheartj/ehac237
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Erratum in
-
Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Endorsed by the International Society for Heart and Lung Transplantation (ISHLT) and the European Reference Network on rare respiratory diseases (ERN-LUNG).Eur Heart J. 2023 Apr 17;44(15):1312. doi: 10.1093/eurheartj/ehad005. Eur Heart J. 2023. PMID: 36821743 No abstract available.
Keywords: Balloon pulmonary angioplasty; Chronic thrombo-embolic pulmonary hypertension; Congenital heart disease; Connective tissue disease; Endothelin receptor antagonists; Guidelines; Left heart disease; Lung disease; Lung transplantation; Phosphodiesterase type 5 inhibitors; Prostacyclin analogues; Prostacyclin receptor agonists; Pulmonary arterial hypertension; Pulmonary endarterectomy; Pulmonary hypertension; Soluble guanylate cyclase stimulators.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
